AstraZeneca PLC (AZNCF)
159.06
+4.45
(+2.88%)
USD |
OTCM |
May 21, 11:50
AstraZeneca Profit Margin (Quarterly): 17.19% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 17.19% |
December 31, 2023 | 7.98% |
September 30, 2023 | 11.96% |
June 30, 2023 | 15.92% |
March 31, 2023 | 16.57% |
December 31, 2022 | 8.04% |
September 30, 2022 | 14.93% |
June 30, 2022 | 3.34% |
March 31, 2022 | 3.39% |
December 31, 2021 | -2.89% |
September 30, 2021 | -16.74% |
June 30, 2021 | 6.69% |
March 31, 2021 | 21.33% |
December 31, 2020 | 13.66% |
September 30, 2020 | 9.85% |
June 30, 2020 | 12.05% |
March 31, 2020 | 12.28% |
December 31, 2019 | 4.70% |
September 30, 2019 | 4.67% |
June 30, 2019 | 2.23% |
March 31, 2019 | 10.80% |
December 31, 2018 | 16.11% |
September 30, 2018 | 8.07% |
June 30, 2018 | 6.79% |
March 31, 2018 | 6.57% |
Date | Value |
---|---|
December 31, 2017 | 22.52% |
September 30, 2017 | 11.01% |
June 30, 2017 | 9.44% |
March 31, 2017 | 9.94% |
December 31, 2016 | 32.98% |
September 30, 2016 | 17.79% |
June 30, 2016 | -0.05% |
March 31, 2016 | 10.56% |
December 31, 2015 | 12.63% |
September 30, 2015 | 12.95% |
June 30, 2015 | 11.05% |
March 31, 2015 | 9.08% |
December 31, 2014 | -4.78% |
September 30, 2014 | 3.84% |
June 30, 2014 | 11.77% |
March 31, 2014 | 7.80% |
December 31, 2013 | -7.55% |
September 30, 2013 | 19.94% |
June 30, 2013 | 13.21% |
March 31, 2013 | 15.83% |
December 31, 2012 | 20.69% |
September 30, 2012 | 22.61% |
June 30, 2012 | 23.98% |
March 31, 2012 | 22.11% |
December 31, 2011 | 16.40% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.74%
Minimum
Sep 2021
21.33%
Maximum
Mar 2021
8.36%
Average
8.95%
Median
Profit Margin (Quarterly) Benchmarks
GSK PLC | 14.21% |
Adaptimmune Therapeutics PLC | -854.2% |
Biodexa Pharmaceuticals Plc | -- |
Verona Pharma PLC | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 16.92% |
Return on Assets | 6.42% |
Return on Invested Capital | 9.45% |
Gross Profit Margin (Quarterly) | 82.51% |
Operating Margin (Quarterly) | 24.57% |
Return on Net Operating Assets | 7.36% |